4.7 Article

Modulation of Chitosan-TPP Nanoparticle Properties for Plasmid DNA Vaccines Delivery

Journal

POLYMERS
Volume 14, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/polym14071443

Keywords

cervical cancer; chitosan-TPP nanoparticles; ionotropic gelation; plasmid DNA vaccine

Funding

  1. CICS-UBI [UIDB/00709/2020, UIDP/00709/2020]
  2. national funds through the Portuguese Foundation for Science and Technology/MCTES

Ask authors/readers for more resources

Nucleic acid vaccines are a fast, safe, cost-effective, and efficient technology for combating viral infections. Developing methods to protect, carry, and deliver nucleic acids is crucial for ensuring their effectiveness.
Nucleic acid vaccines have become a revolutionary technology to give a fast, safe, cost-effective and efficient response against viral infections, such as SARS-CoV-2 or Human papillomavirus (HPV). However, to ensure their effectiveness, the development of adequate methods to protect, carry, and deliver nucleic acids is fundamental. In this work, nanoparticles (NPs) of chitosan (CS)-tripolyphosphate (TPP)-plasmid DNA (pDNA) were thoroughly modulated and characterized, by measuring the charge and size through dynamic light scattering (DLS) and morphology by scanning electron microscopy (SEM). Stability, cytotoxicity and cellular uptake of NPs were also evaluated. Finally, the effect of polyplexes on the expression of HPV E7 antigen in human fibroblast and RAW cells was investigated through polymerase chain reaction (PCR) and real-time PCR. The results showed NPs with a spherical/oval shape, narrow size distribution <180 nm and positive zeta potentials (>20 mV) and good stability after one month of storage at 4 degrees C in formulation buffer or when incubated in culture medium and trypsin. In vitro studies of NPs cytotoxicity revealed that the elimination of formulation buffers led to an improvement in the rate of cell viability. The E7 antigen transcription was also increased for NPs obtained with high pDNA concentration (60 mu g/mL). The analyzed CS-TPP-pDNA polyplexes can offer a promising vehicle for nucleic acid vaccines, not only in the prevention or treatment of viral infections, but also to fight emergent and future pathogens.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available